Manoj N Appointed Chief Vigilance Officer at Karnataka Antibiotics & Pharmaceuticals Limited

Manoj N, who joined the Indian Railway Traffic Service in the 2013 batch, has been appointed Chief Vigilance Officer at Karnataka Antibiotics & Pharmaceuticals Limited, Bengaluru, a Central public sector undertaking under the Department of Pharmaceuticals, placing him at the head of the company's internal vigilance function with statutory reporting obligations to the Central Vigilance Commission, according to an order issued this week.

The Chief Vigilance Officer post at Central PSUs is filled through a process coordinated by the Department of Personnel and Training in consultation with the Commission, drawing officers from various organised Central services who have completed a minimum tenure in their parent cadre. IRTS officers, who manage traffic and commercial operations across Indian Railways, are regularly represented in such postings, given the selection process's emphasis on administrative experience and a demonstrated record of integrity in prior assignments. The Commission maintains an empanelled list of eligible officers from which such vacancies are filled, refreshed periodically as officers complete their existing tenures or become newly eligible.

KAPL, a joint venture between the Government of India and the Government of Karnataka, has historically focused on manufacturing antibiotics and other pharmaceutical formulations within the wider public sector pharmaceutical manufacturing sector the Department of Pharmaceuticals oversees. Its vigilance function is responsible for preventive measures such as reviewing procurement processes and internal systems for vulnerabilities, alongside examining specific complaints or irregularities referred to it. Companies of KAPL's size typically maintain a vigilance unit that also handles annual property returns scrutiny and periodic inspection of stores and purchase records as part of its preventive mandate.

The role is structurally distinct from the rest of a PSU's management: the officer reports to the company's chief executive on administrative matters and to the Central Vigilance Commission on substantive vigilance matters, a dual-reporting design meant to preserve independence even while the officer remains embedded in day-to-day operations. Tenures for such postings are fixed for a defined period, generally a minimum of three years and extendable depending on performance and organisational needs, after which the officer either returns to their parent service or moves to another assignment.

For Manoj N, the appointment marks a shift from the operational and commercial responsibilities typical of an IRTS officer's Railway career to a specialised vigilance role within a smaller, pharmaceutical-sector PSU, reflecting the broader practice of drawing CVOs from a wide pool of Central services rather than restricting the role to any single cadre.

The Commission's guidelines require such postings to be filled from a panel of eligible officers cleared in advance, with the Commission retaining oversight of the selection to preserve the role's independence, giving the appointed officer sufficient time to build a working understanding of the PSU's internal systems before any eventual handover to a successor.

KAPL's vigilance function will now be headed by an officer from outside the pharmaceutical sector, a common feature of CVO appointments across Central PSUs, where the emphasis falls on administrative integrity and process familiarity rather than sector-specific technical expertise. Manoj N's tenure at KAPL will typically run alongside the company's annual vigilance awareness activities, which most Central PSUs conduct in coordination with the Commission's broader calendar of preventive vigilance programmes.